U2OS human osteosarcoma cells were grown in Dulbecco’s Modified Eagle Medium (DMEM, Sigma) supplemented with 10% fetal bovine serum (FBS, Sigma, St. Louis, MO, USA) and 2 mM Ala–Gln (#G8541, Sigma). Mammalian expression plasmid, pRK5 β-catenin, has been previously reported [27]. pRK5 β-catenin variants were made by PCR oligonucleotide site-directed mutagenesis, as described [28]. Plasmids used for luciferase assays were pEZX-PG04 SEAP (GeneCopoeia, Rockville, MD, USA), pGL4.27 luc2P (#E8451; Promega, Madison, WI, USA), and pGL4.49 luc2P TCF/LEF (#E4611; Promega). U2OS cells were transfected using Effectene (Qiagen) transfection reagent following manufacturer’s recommendation.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.